ESR1 and metabolic dysfunction-associated steatotic liver disease: Numerous studies have demonstrated that nuclear ERs’ (mainly ERα) signaling exerts a crucial role in the benefits of estrogen on hepatic steatosis challenged by a high-fat diet (HFD), and ERα is deemed as an important target for the anti-NAFLD (14, 15).